Pre-qualification seen as significant step towards self-sufficiency in healthcare in continent where more than 70% of drugs are imported
A Kenyan pharmaceutical company, Universal Corporation Limited, has become the first manufacturer in Africa to receive the World Health Organization (WHO) quality guarantee for a lifesaving malaria drug.
The antimalarial drug, sulfadoxine-pyrimethamine plus amodiaquine (Spaq), is frequently used to prevent seasonal malaria in children during months of peak transmission periods such as rainy seasons. Previously, demand for drugs such as Spaq in Africa has been met through the importation of generic versions of the medicine from India and China.
About Author
More Stories
Australia news live: Jacinta Nampijinpa Price confirms she will run for Liberal deputy, days after defecting from Nationals
Five fishermen lost at sea for 55 days rescued by Ecuadorian tuna boat
NSW forestry agency should be shut down for repeatedly breaking law, critics argue